1. 1-2 of 2
    1. Bevacizumab versus Ranibizumab — The Verdict

      Explore The New England Journal of Medicine (Apr 28 2011)

      For 5 years, patients and clinicians have wrestled with the choice between two drugs for the treatment of neovascular age-related macular degeneration (AMD), a common cause of irreversible blindness among the elderly worldwide. (Read Full Article)

      Mentions:   Bascom Palmer Eye Institute   Genentech

    2. Poppers-Associated Retinal Toxicity

      Explore The New England Journal of Medicine (Oct 13 2010)

      Here, we describe four patients who were seen within a few months of one another and who had prolonged visual loss as a result of damage to foveal photoreceptors shortly after inhaling poppers. (Read Full Article)

    1-2 of 2